{
  "ticker": "LLY",
  "target_date": "2025-04-03",
  "actual_date": "2025-04-03",
  "collected_at": "2025-12-08T11:35:55.265060",
  "price": {
    "open": 805.9,
    "high": 814.13,
    "low": 782.58,
    "close": 784.5978393554688,
    "volume": 2675100,
    "change_1d_pct": -3.56,
    "change_7d_pct": -7.42,
    "change_30d_pct": -9.62
  },
  "technicals": {
    "rsi_14": 43.08,
    "sma_20": 822.86,
    "sma_50": 842.39,
    "macd": -12.118,
    "macd_signal": -7.619,
    "macd_histogram": -4.498,
    "bb_upper": 861.76,
    "bb_lower": 783.96,
    "price_vs_sma20_pct": -4.65,
    "price_vs_sma50_pct": -6.86,
    "volume_ratio": 0.79
  },
  "fundamentals": {
    "market_cap": 889809534976,
    "pe_ratio": 48.63229,
    "forward_pe": 43.8034,
    "price_to_book": 37.371426,
    "price_to_sales": 14.974967,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.74,
    "pct_from_52w_low": 59.12
  },
  "macro": {
    "spy": {
      "price": 533.64,
      "change_1d_pct": -4.93,
      "change_7d_pct": -5.61
    },
    "vix": {
      "level": 30.02,
      "signal": "HIGH_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.05
    },
    "dollar_index": {
      "level": 102.07
    },
    "gold": {
      "price": 3097.0
    },
    "regime": "BEAR_HIGH_VOL"
  },
  "news": [
    {
      "headline": "Top 50 High-Quality Dividend Growth Stocks For April 2025",
      "source": "SeekingAlpha",
      "datetime": 1743722900,
      "summary": "8 high-quality dividend stocks with top return potential for 2025. Click here for a detailed analysis.",
      "url": "https://finnhub.io/api/news?id=7e164db62b82712493c6c3ac3658c57e9cc854ca8b7bd166867e1c6f8ba49c6d"
    },
    {
      "headline": "Voya Corporate Leaders Trust Fund B Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1743722520,
      "summary": "For the quarter, Voya Corporates Leaders Trust Fund Series B underperformed its benchmark, S&P 500 Index on a net asset value basis, primarily due to selection effects.",
      "url": "https://finnhub.io/api/news?id=748f3481ec49c2de282915ec9d756a88810d29de334c3771b85e2474e5315fc5"
    },
    {
      "headline": "Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly",
      "source": "MarketWatch",
      "datetime": 1743698700,
      "summary": "Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly",
      "url": "https://finnhub.io/api/news?id=15e650d6627ab1afef50fab6f0596ba8355833094c355939abb6aa20508f4199"
    },
    {
      "headline": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1743697860,
      "summary": "Eli Lilly & Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f3bf30a5e0c4d7051d6abb443519b95c6ca51ba578fb023c13170f28bd4598b0"
    },
    {
      "headline": "Sangamo Therapeutics Enters Capsid License Agreement With Lilly",
      "source": "MarketWatch",
      "datetime": 1743697800,
      "summary": "Sangamo Therapeutics Enters Capsid License Agreement With Lilly",
      "url": "https://finnhub.io/api/news?id=b732458dfff5c876602d24fa781ae555a89c644edf7cc718097dbd2e6354a846"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742416067.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/xslF345X05/wk-form4_1742416067.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415936.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000101/xslF345X05/wk-form4_1742415936.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415842.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000099/xslF345X05/wk-form4_1742415842.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415665.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000097/xslF345X05/wk-form4_1742415665.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415462.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000095/xslF345X05/wk-form4_1742415462.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}